pentobarbital will minimize the extent or influence of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Use of alternative treatments is strongly suggested when linagliptin would be to be administered having a CYP3A4 inducerPhenobarbital has the bottom lipid solubility, lowest plasma binding, least e